Undisclosed worldwide leading animal health company

Zoetis is the world's leading animal health company, specializing in the discovery, development, and manufacture of medicines, vaccines, and diagnostic products for pets and livestock. Spun off from Pfizer in 2013, the company operates in over 100 countries and maintains a dominant market share in the companion animal and production animal sectors. Its extensive portfolio includes industry-leading brands such as Apoquel, Cytopoint, and Simparica, which address critical needs in dermatology and parasitology. Zoetis is a pioneer in veterinary monoclonal antibody therapy, having launched the first-of-their-kind treatments for chronic pain and allergic skin diseases in dogs and cats. Beyond therapeutics, the company provides genetic testing, biodevices, and precision livestock farming solutions to enhance animal productivity and welfare. With a robust R&D engine and a global manufacturing footprint, Zoetis continues to drive innovation in areas like oncology, immunology, and infectious disease prevention.